How LiveRamp's AI Push and Equity Plan Changes (RAMP) Are Reshaping Its Investment Narrative

LiveRamp Holdings, Inc. +0.04% Pre

LiveRamp Holdings, Inc.

RAMP

26.53

26.53

+0.04%

0.00% Pre
  • LiveRamp Holdings recently reported an 11% year-over-year increase in first-quarter revenue, with its strategic focus on AI-powered advertising drawing investor attention, while its CTO Mohsin Hussain sold 12,734 shares on September 8, 2025, and shareholders approved an amendment to the 2005 Equity Compensation Plan, increasing available shares by 2,500,000.
  • The company’s emphasis on AI-driven advertising and privacy-focused data solutions amid a rapidly evolving digital landscape highlights its proactive adaptation to industry trends and regulatory shifts.
  • To assess the impact of LiveRamp’s growing AI focus on its outlook, we’ll explore how these initiatives may influence the investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

LiveRamp Holdings Investment Narrative Recap

To be a LiveRamp shareholder, you need to believe that its AI-driven advertising and privacy-focused data solutions will outpace intense competition and regulatory changes, fueling sustainable growth in digital marketing. The recent uptick in first-quarter revenue and increased attention to AI initiatives provide momentum, but high valuation and conservative guidance remain important balancing factors. The announced share sale by the CTO is unlikely to materially shift the near-term outlook, while concentration risk from reliance on a small number of large clients stands out as the primary immediate risk.

Among recent updates, the shareholder approval to amend the 2005 Equity Compensation Plan and authorize 2,500,000 more shares is highly relevant. This decision affects the company’s flexibility for employee incentives and retention, which could help attract top talent for AI and data privacy advancement, one of the most visible growth catalysts, and potentially support operational execution in an increasingly competitive sector.

However, investors should be alert: unlike its double-digit sales growth, LiveRamp’s customer base remains highly concentrated, and if...

LiveRamp Holdings' narrative projects $969.7 million in revenue and $154.0 million in earnings by 2028. This requires 8.3% yearly revenue growth and a $141.3 million increase in earnings from $12.7 million today.

Uncover how LiveRamp Holdings' forecasts yield a $39.62 fair value, a 45% upside to its current price.

Exploring Other Perspectives

RAMP Community Fair Values as at Sep 2025
RAMP Community Fair Values as at Sep 2025

Simply Wall St Community members submitted four fair value estimates for LiveRamp from US$28 to US$52.78 per share, reflecting a wide spectrum of outlooks. While many see room for upside amid AI advancement, concentration risk and high valuation remain critical themes influencing future returns, reminding you to examine multiple viewpoints before making decisions.

Explore 4 other fair value estimates on LiveRamp Holdings - why the stock might be worth as much as 94% more than the current price!

Build Your Own LiveRamp Holdings Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your LiveRamp Holdings research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free LiveRamp Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate LiveRamp Holdings' overall financial health at a glance.

Looking For Alternative Opportunities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
  • Outshine the giants: these 26 early-stage AI stocks could fund your retirement.
  • This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.